VMP 39708511000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Dihydrocodeine 30mg tablets
BNF code 0407020G0AAACAC
Virtual Therapeutic Moiety Dihydrocodeine
Date identifier became valid 26 May 2021
Previous product identifier 322539003
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Dihydrocodeine tartrate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 30.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category Schedule 5 (CD Inv)
Actual Medicinal Products
Dihydrocodeine 30mg tablets (A A H Pharmaceuticals Ltd)
Dihydrocodeine 30mg tablets (Accord Healthcare Ltd)
Dihydrocodeine 30mg tablets (Alliance Healthcare (Distribution) Ltd)
Dihydrocodeine 30mg tablets (Almus Pharmaceuticals Ltd)
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd)
Dihydrocodeine 30mg tablets (DE Pharmaceuticals)
Dihydrocodeine 30mg tablets (M & A Pharmachem Ltd)
Dihydrocodeine 30mg tablets (Medihealth (Northern) Ltd)
Dihydrocodeine 30mg tablets (Phoenix Healthcare Distribution Ltd)
Dihydrocodeine 30mg tablets (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Dihydrocodeine 30mg tablets 100 tablet
Dihydrocodeine 30mg tablets 28 tablet
Dihydrocodeine 30mg tablets 30 tablet
Dihydrocodeine 30mg tablets 500 tablet

dm+d data retrieved from TRUD: release NHSBSA_1.3.0_20220124000001, imported on 25th January 2022 at 04:13:55.